Extra-pulmonary vein drivers as a potential mechanism of the antiarrhythmic drug-resistant atrial fibrillation after catheter ablation: Digital twin-guided virtual drug test
Accurate prediction of the most effective antiarrhythmic drug (AAD) following atrial fibrillation (AF) ablation offers substantial clinical value. Nevertheless, in vivo pharmacologic testing and driver mapping present significant technical and ethical challenges. To evaluate whether combined restitution an...